Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 772 Jul 12 – Oct 9, 2026
- Disclosed funding
- $67.1B 615 disclosed amounts
- Median round
- $22.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| AT Adjuvia TherapeuticsCompany profile Adjuvia develops oral nanoparticle therapies intended to address mitochondrial dysfunction, starting with its ATI-105 program for rare diseases. Adjuvia develops oral nanoparticle therapies intended to address mitochondrial dysfunction, starting with its ATI-105 program for rare diseases. | $8M | Seed | Biotech | United States | Investors | |
| A ArchCompany profile Arch helps investors, advisers and family offices administer private-market portfolios by collecting documents, standardizing data and coordinating investment workflows. Arch helps investors, advisers and family offices administer private-market portfolios by collecting documents, standardizing data and coordinating investment workflows. | $52M | Series B | Fintech | United States | Investors | |
| C ChipAgentsCompany profile ChipAgents develops AI tools that turn chip specifications and code into RTL, verification assets and root-cause analysis. ChipAgents develops AI tools that turn chip specifications and code into RTL, verification assets and root-cause analysis. | $60M | Series A+Series A | Hardware | United States | Investors | |
| PB Physician-led behavioral health services and technology company | $14.2M | Growth | Healthtech | United States | Investors | |
| C CopySightCompany profile AI IP governance platform for copyright risk management in AI-generated content AI IP governance platform for copyright risk management in AI-generated content | $3M | Seed | Enterprise software | United States | Investors | |
| TB Developing nerve-targeted imaging technologies for surgery. | Undisclosed | Series A | Biotech | United States | Investors | |
| EA Develops enterprise AI agents for revenue-generating customer interactions. | $30M | Series A | Enterprise software | United States | Investors | |
| OS Secure AI control plane for the enterprise. | $113M | Series B | Cybersecurity | United States | Investors | |
| D A software-first registered agent that automates state filings. | $10M | Series A | Enterprise software | United States | Investors | |
| T ThreatLockerCompany profile Zero Trust cybersecurity platform for endpoints, networks, and cloud systems Zero Trust cybersecurity platform for endpoints, networks, and cloud systems | $190M | Series FSeries C+ | Cybersecurity | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 12, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
55rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
40rounds15led - 3Khosla Ventures
Arena, Vinci, Conway Research
25rounds5led - 4Sequoia Capital
TypeSafe AI, Mecka, Healthleap
23rounds5led - 5Insight Partners
Stuut, Hestus, Inc., Quartermaster
21rounds9led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.